Literature DB >> 15237365

Disparity in use of orthotopic liver transplantation among blacks and whites.

Andrea E Reid1, Maria Resnick, YuChiao Chang, Nathan Buerstatte, Joel S Weissman.   

Abstract

Orthotopic liver transplantation (OLT) is the best treatment for end-stage liver disease. Limited data exist on the access of minorities to OLT. The aim of this study was to determine whether disparities exist among black and white OLT patients. Data were collected from the United Network for Organ Sharing on black and white 18-70 year-old OLT waiting list registrants (n = 29,013) and OLT recipients (n = 15,805) between 1994 and 1998. Standardized transplant ratios were generated by comparing the racial distribution of OLT patients with the US population. Demographic and clinical characteristics of OLT registrants were compared by race. Multivariate analyses were performed to identify predictors of time to OLT and the likelihood of dying or receiving OLT within 4 years, controlling for severity of illness and other factors. The standardized transplant ratio for black OLT recipients (0.65) was significantly lower than the standardized transplant ratio for white OLT recipients (1.05). Blacks were younger and sicker than whites. After adjustment for severity and other factors, time to OLT among recipients did not differ by race (P >.05). Blacks were more likely to die or become too ill for OLT while waiting (P <.001). Blacks were less likely to receive OLT within 4 years (P <.001). In conclusion, adult blacks were underrepresented among OLT patients. Although waiting times were similar once listed, black race affected outcomes while awaiting OLT. The process of referral and evaluation for OLT should be investigated further.

Entities:  

Mesh:

Year:  2004        PMID: 15237365     DOI: 10.1002/lt.20174

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  36 in total

1.  Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease.

Authors:  Hashem El-Serag; Katherine A McGlynn; Garth N Graham; Samuel So; Charles D Howell; Ted Fang; Janelle Tangonan Anderson; Thelma King Thiel
Journal:  J Fam Pract       Date:  2010-04       Impact factor: 0.493

2.  Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations.

Authors:  Christopher L Bowlus; Chin-Shang Li; Tom H Karlsen; Benedicte A Lie; Carlo Selmi
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

3.  Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival.

Authors:  Dana Sloane; Hegang Chen; Charles Howell
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

4.  Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.

Authors:  Christopher J Sonnenday; Justin B Dimick; Richard D Schulick; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2007-10-03       Impact factor: 3.452

5.  Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs.

Authors:  Mary Amanda Dew; Andrea F DiMartini; Jennifer Steel; Annette De Vito Dabbs; Larissa Myaskovsky; Mark Unruh; Joel Greenhouse
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

Review 6.  Disparities in the provision of medical care: an outcome in search of an explanation.

Authors:  Elizabeth A Klonoff
Journal:  J Behav Med       Date:  2009-01-06

7.  Ethnic disparities in liver transplantation.

Authors:  Nyingi Kemmer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

8.  Geographic inequity in access to livers for transplantation.

Authors:  Heidi Yeh; Elizabeth Smoot; David A Schoenfeld; James F Markmann
Journal:  Transplantation       Date:  2011-02-27       Impact factor: 4.939

9.  Liver cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Behnoosh R Momin; Paulo S Pinheiro; Helena Carreira; Chunyu Li; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

10.  Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States.

Authors:  Jin Ge; John P Roberts; Jennifer C Lai
Journal:  Clin Transplant       Date:  2017-06-19       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.